Skip to content

EverFlex™ Protégé™ EverFlex™ PRB35-08-150-120Recalls & reported problems

Ev3, Inc · STENT PRB35-08-150-120 PROTEGE EF V07 · Class 3 · Implant

All models of EverFlex Protégé EverFlex (27)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00821684060322), received between Feb 16, 2026 and Feb 16, 2026 — classified as 1 malfunction.

The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).

3 other recalls cover devices cleared under the same FDA submission (P110023); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Activation, Positioning or Separation Problem1
  • Detachment of Device or Device Component1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 16, 2026Activation, Positioning or Separation Problem; Detachment of Device or Device Component

    IT WAS REPORTED THAT DURING A PROCEDURE TO TREAT A CHRONIC TOTAL OCCLUSION OF THE LEFT SUPERFICIAL FEMORAL ARTERY USING THE STENT PR B35-08-150-120 PROTEGE EF V10 AND STENT PRB35-07-150-120 PROTEGE EF V10, THERE WERE DEPLOYMENT ISSUES. THE FIRST STENT COULD NOT BE DEPLOYED, AND THE HANDLE BROKE DURING THE ATTEMPTED DEPLOYMENT. WHEN A SECOND STENT WAS USED, THERE WAS DIFFICULTY DEPLOYING IT AS WELL. BOTH DEVICES WERE SAFELY REMOVED WITHOUT EXPOSING ANY STENT STRUTS OR REQUIRING INTERVENTION FOR REMOVAL. THE VESSEL WAS PRE-DILATED WITH A 4/80 NANO DEVICE AND POST-DILATED WITH A 6/120 PACIFIC PLUS DEVICE. NO PATIENT SYMPTOMS, COMPLICATIONS, ADVERSE EVENTS, INFECTIONS, DEATHS, OR IRREGULARITIES WERE REPORTED. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24342945 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P110023. One submission often covers many models, so check the product and lot details in each record.

  • Z-0623-2024 · Nov 20, 2023 · Completed
    Protege GPS Self-Expanding Peripheral Stent System, product number SERB65-09-60-80, Sterile.
  • Z-1644-2022 · Jul 14, 2022 · Open, Classified
    EverFlex Self-Expanding Peripheral Stent with Entrust Delivery System
  • Z-2048-2016 · May 23, 2016 · Terminated
    EV3 EverFiex" Self-expanding Peripheral Stent System, Sterilized using Ethylene Oxide, Rx Only, PRB35-08-040-080. The Protege EverFiex" Self-expanding Peripheral Stent System is a

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page